CryoPort Inc

+2.72 (+6.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.08B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$70.6 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$37.91
50-Day MA$31.39
200-Day MA$41.98
See more pivots

CryoPort Inc Stock, NASDAQ:CYRX

112 Westwood Place, Suite 350, Brentwood, Tennessee 37027
United States of America
Phone: +1.949.470.2300
Number of Employees: 847


CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.